[EN] NOVEL COMPOUNDS AS WIP1 INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS EN TANT QU'INHIBITEURS DE WIP1
申请人:GLAXOSMITHKLINE LLC
公开号:WO2012149102A1
公开(公告)日:2012-11-01
This invention relates to the use of acylated alanine derivatives for the modulation, notably the inhibition of the activity of WIP1. Suitably, the present invention relates to the use of acylated alanine derivatives in the treatment of cancer.